Press Releases

Press Releases

Samsung Biologics Receives Health Canada Approval

Samsung Biologics Receives Health Canada Approval 

?

- Additional global regulatory agencies’ approval following with FDA, EMA, and PMDA
- Also received DP EMA approval, One-Stop Service from DS to DP

 


'18. 06. 21st (Thurs)

 

 

Samsung Biologics Receives Health Canada Approval

[Incheon, Korea] June 21st, 2018 ? Samsung Biologics announced today that it has licensed by the Health Canada for manufacturing a monoclonal antibody Drug Substance at its first plant.

 

This is a great milestone for Samsung Biologics as it is another global regulatory agency’ approval in addition to FDA, EMA, and PMDA. With the additional two approvals, Samsung Biologics has received 14 global manufacturing approvals for 14 biologics products.

 

Samsung Biologics is continuously receiving approvals at an accelerated rate and the number of global approvals is expected to be reach 30 within this year.
 
Samsung Biologics also received an approval for its Drug Product manufacturing from EMA. This is the company’s second drug product and third global approval. 

 

TH Kim, CEO and President of Samsung Biologics, said “Samsung Biologics has grown rapidly during the last seven years with 14 global regulatory agency approvals and 362,000 liters biologics manufacturing capacity” Then he added “We will change the paradigm of the bio industry with innovation and ultimately benefit the patients by providing the biologics drugs in a timely manner at lower cost”

 

 

 

Samsung Biologics Receives Health Canada Approval 

- Additional global regulatory agencies’ approval following with FDA, EMA, and PMDA
- Also received DP EMA approval, One-Stop Service from DS to DP

 


'18. 06. 21st (Thurs)

 

 

Samsung Biologics Receives Health Canada Approval

[Incheon, Korea] June 21st, 2018 – Samsung Biologics announced today that it has licensed by the Health Canada for manufacturing a monoclonal antibody Drug Substance at its first plant.

 

This is a great milestone for Samsung Biologics as it is another global regulatory agency’ approval in addition to FDA, EMA, and PMDA. With the additional two approvals, Samsung Biologics has received 14 global manufacturing approvals for 14 biologics products.

 

Samsung Biologics is continuously receiving approvals at an accelerated rate and the number of global approvals is expected to be reach 30 within this year. 
 
Samsung Biologics also received an approval for its Drug Product manufacturing from EMA. This is the company’s second drug product and third global approval. 

 

TH Kim, CEO and President of Samsung Biologics, said “Samsung Biologics has grown rapidly during the last seven years with 14 global regulatory agency approvals and 362,000 liters biologics manufacturing capacity” Then he added “We will change the paradigm of the bio industry with innovation and ultimately benefit the patients by providing the biologics drugs in a timely manner at lower cost”

 

 

 

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION